Published in Br J Haematol on November 01, 1995
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function. Blood (1978) 1.47
Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest (1980) 1.45
An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest (1995) 1.33
Targeted mutagenesis of SV40 DNA induced by UV light. Nature (1983) 1.33
Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol (1981) 1.11
Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res (1995) 1.00
Distribution of ultraviolet-induced lesions in simian virus 40 DNA. Biochimie (1985) 0.95
Error-prone replication of ultraviolet-irradiated simian virus 40 in carcinogen-treated monkey kidney cells. Biochimie (1983) 0.92
HPA-10w(b) (La(a)): genetic determination of a new platelet-specific alloantigen on glycoprotein IIIa and its expression in COS-7 cells. Blood (1997) 0.88
Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease. Br J Haematol (2000) 0.87
Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium. J Thromb Haemost (2003) 0.85
Two different beta3 cysteine substitutions alter alphaIIb beta3 maturation and result in Glanzmann thrombasthenia. Thromb Haemost (2002) 0.83
Molecular analysis of mutagenesis in mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.83
Ultrastructural analysis of bone marrow hematopoiesis in mice transgenic for the thymidine kinase gene driven by the alpha IIb promoter. Blood (1998) 0.83
The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition. J Thromb Haemost (2013) 0.83
New approaches to determination of specific functions of platelet membrane sites. Nature (1976) 0.83
Analysis of VH and VL genes of a monospecific human anti-myosin antibody produced by a B cell from the primary repertoire. Hum Antibodies (1999) 0.82
A case of profound and prolonged tirofiban-induced thrombocytopenia and its correction by intravenous immunoglobulin G. J Thromb Haemost (2007) 0.81
Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexes. C R Acad Sci III (1996) 0.79
Homozygous Cys542-->Arg substitution in GPIIIa in a Swiss patient with type I Glanzmann's thrombasthenia. Br J Haematol (1999) 0.79
[Platelet membrane glycoprotein defect, molecular basis for the abnormal adhesion of platelets to the subendothelium in thrombocytic hemorrhagic dystrophy]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.79
Linkage of four polymorphisms on the alphaIIb gene. Br J Haematol (1998) 0.79
Improving selection of alphaIIbbeta3-binding phage antibodies with increased reactivity derived from immunized donors. Clin Immunol (2003) 0.78
Double heterozygosity of the GPIIb gene in a Swiss patient with Glanzmann's thrombasthenia. Br J Haematol (1998) 0.78
Family screening for a Glanzmann's thrombasthenia mutation using PCR-SSCP. Platelets (1998) 0.78
Mechanisms and consequences of mutation induction in mammalian cells. Int J Radiat Biol (1990) 0.77
Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus. Thromb Res (1999) 0.77
DNA synthesis blocking lesions induced by singlet oxygen are targeted to deoxyguanosines. Nucleic Acids Res (1992) 0.77
[Reference center for platelet diseases]. Arch Pediatr (2007) 0.76
Two-way trafficking of membrane glycoproteins on thrombin-activated human platelets. Semin Hematol (1994) 0.75
Glanzmann's thrombasthenia due to a point mutation within intron 10 results in aberrant splicing of the beta3 gene. J Thromb Haemost (2003) 0.75
[Functions of thrombin receptors in the reversible distribution of platelet surface glycoprotein I balpha in activated platelets]. Zhonghua Xue Ye Xue Za Zhi (2005) 0.75
Non-radioactive SSCP for genotyping human platelet alloantigens. Br J Haematol (1995) 0.75
Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100. Platelets (1998) 0.75
A patient with autoimmune thrombocytopenic purpura demonstrating serum antibodies reactive with mouse cross-reactive idiotypes. Clin Immunol Immunopathol (1995) 0.75
Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders. Hum Antibodies (1997) 0.75
A different organization of bound carbohydrate within cat platelet membranes. Thromb Haemost (1977) 0.75
Glycoprotein-sialyltransferase activity of normal human, thrombasthenic and Bernard-Soulier platelets. Vox Sang (1981) 0.75
Efficient RT-PCR on platelet mRNA after long-term storage. Br J Haematol (1997) 0.75
[Bernard-Soulier syndrome from the clinical description (1948) to the molecular era (1977) (author's transl)]. Nouv Rev Fr Hematol Blood Cells (1977) 0.75
Autoantibodies and anti-mouse antibodies in thrombocytopenic patients as assessed by different MAIPA assays. Br J Haematol (1996) 0.75
The use of animal virus or shuttle vectors to characterize mutagenesis in mammalian cells. Prog Clin Biol Res (1986) 0.75
Detection of an acquired platelet storage pool disease in three patients with a myeloproliferative disorder. Thromb Haemost (1979) 0.75
Carcinogen-induced mutagenesis in the simian virus 40 genome. Ann Ist Super Sanita (1989) 0.75